Carole Belanger

This inventor holds 12 USPTO granted patents and 3 published patent applications, plus 1 CIPO patent and 7 EPO patents. Top assignee: Genfit. Active years: 2018-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Carole Belanger. Retrieved from https://idiyas.com/inventor/carole-belanger

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 12 (Patent Applications = 3)

% Patents Active = 91.7

CIPO Patents = 1 (Patent Applications = 6)

EPO Patents = 7 (Patent Applications = 10)

Average Co-Inventor Count = 5.3

ph-index = 3

Forward Citations = 37(Granted Patents)

Company Filing History:

12 out of 72

Genfit

patents

Years Active: 2018-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12053456 - Pharmaceutical compositions for combination therapy (2024-08-06),

2. 11590108 - Pharmaceutical compositions for combination therapy (2023-02-28),

3. 11484517 - Combination comprising a PPAR agonist such as elafibranor and an acetyl-CoA carboxylase (ACC) inhibitor (2022-11-01),

4. 11478440 - Combination of Elafibranor or derivatives thereof with an anti-NASH, anti-fibrotic or anti-cholestatic agent (2022-10-25),

5. 11191749 - Pharmaceutical compositions for combination therapy (2021-12-07),

6. 11103484 - Methods of treatment for cholestatic and fibrotic diseases (2021-08-31),

7. 11033534 - Pharmaceutical compositions for combination therapy (2021-06-15),

8. 10905680 - Methods of treatment for cholestatic and fibrotic diseases (2021-02-02),

9. 10130613 - Methods of treatment for cholestatic and fibrotic diseases (2018-11-20),

10. 10130612 - Methods of treatment for cholestatic and fibrotic diseases (2018-11-20),

11. 10117856 - Methods of treatment for cholestatic and fibrotic diseases (2018-11-06),

12. 10117855 - Methods of treatment for cholestatic and fibrotic diseases (2018-11-06),

Title: The Innovative Journey of Carole Belanger

Introduction

Carole Belanger, an accomplished inventor based in Bondues, France, has made significant contributions to the field of pharmaceuticals. With a remarkable portfolio of 12 patents, her work primarily revolves around developing advanced therapeutic compositions aimed at treating various diseases.

Latest Patents

Among her latest innovations are groundbreaking patents for pharmaceutical compositions for combination therapy. These inventions focus on a combination product and its application in therapy, as well as the integration of active ingredients to enhance treatment effectiveness. Her research emphasizes the importance of innovative solutions in addressing complex health challenges.

Career Highlights

Carole is currently a key member of the team at Genfit, a company dedicated to advancing medical research and improving patient outcomes. Her expertise in pharmacology and her dedication to innovation have positioned her at the forefront of pharmaceutical development.

Collaborations

Throughout her career, Carole has collaborated with notable professionals such as Robert Walczak and Raphael Darteil. These collaborations have not only enriched her research but have also contributed to a collaborative environment that fosters innovation within the pharmaceutical industry.

Conclusion

Carole Belanger's pioneering work and dedication to developing pharmaceutical compositions highlight her role as a leading inventor in her field. With each patent, she continues to pave the way for new therapeutic options, showcasing the impactful intersection of innovation and healthcare.

Profile summary based on public USPTO records.